$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015736 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$300.7M	$297.2M	$300.9M
YoY Change	6.4%	10.24%	13.74%
Cost Of Revenue	$180.1M	$183.1M	$186.6M
YoY Change	2.73%	9.13%	11.49%
Gross Profit	$120.6M	$114.0M	$114.4M
YoY Change	12.39%	12.09%	17.63%
Gross Profit Margin	40.11%	38.37%	38.0%
Selling, General & Admin	$10.57M	$10.35M	$11.44M
YoY Change	6.76%	2.54%	12.06%
% of Gross Profit	8.77%	9.07%	10.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.338M	$10.59M	$11.77M
YoY Change	-7.39%	5.35%	12.31%
% of Gross Profit	7.74%	9.28%	10.29%
Operating Expenses	$98.06M	$98.36M	$94.18M
YoY Change	5.2%	7.35%	2.61%
Operating Profit	$22.52M	$15.63M	$20.18M
YoY Change	61.12%	56.1%	271.29%
Interest Expense	$0.00	$46.00K	$11.95M
YoY Change	-100.0%	-53.06%	-782.96%
% of Operating Profit	0.0%	0.29%	59.2%
Other Income/Expense, Net	$4.956M	$5.685M	$4.544M
YoY Change	34.09%	31.51%
Pretax Income	$36.60M	$35.71M	$36.67M
YoY Change	63.96%	127.17%	394.6%
Income Tax	$9.494M	$9.462M	$8.700M
% Of Pretax Income	25.94%	26.49%	23.73%
Net Earnings	$26.84M	$26.21M	$28.41M
YoY Change	64.88%	123.6%	347.13%
Net Earnings / Revenue	8.93%	8.82%	9.44%
Basic Earnings Per Share	$1.74	$1.71
Diluted Earnings Per Share	$1.73	$1.69	$1.83
COMMON SHARES
Basic Shares Outstanding	15.40M	15.35M	15.32M
Diluted Shares Outstanding	15.56M	15.51M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$410.9M	$371.0M	$372.7M
YoY Change	22.03%	19.83%	14.87%
Cash & Equivalents	$136.2M	$93.98M	$107.1M
Short-Term Investments	$274.7M	$277.0M	$265.6M
Other Short-Term Assets	$61.12M	$67.17M	$66.18M
YoY Change	3.56%	6.56%	3.46%
Inventory	$6.632M	$6.763M	$7.386M
Prepaid Expenses
Receivables	$109.4M	$125.7M	$108.5M
Other Receivables	$713.0K	$487.0K	$503.0K
Total Short-Term Assets	$447.9M	$417.6M	$406.2M
YoY Change	21.46%	23.58%	14.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$487.2M	$488.7M	$493.3M
YoY Change	-2.93%	-2.87%	-2.61%
Goodwill	$168.3M	$168.3M	$168.3M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$7.038M	$7.038M	$7.038M
YoY Change	0.0%	0.0%	0.0%
Long-Term Investments	$20.19M	$16.75M	$16.27M
YoY Change	503.32%	365.97%	689.66%
Other Assets	$404.6M	$413.4M	$411.2M
YoY Change	-1.32%	-2.59%	-0.9%
Total Long-Term Assets	$891.8M	$902.1M	$904.6M
YoY Change	-2.21%	-2.74%	-1.84%
TOTAL ASSETS
Total Short-Term Assets	$447.9M	$417.6M	$406.2M
Total Long-Term Assets	$891.8M	$902.1M	$904.6M
Total Assets	$1.340B	$1.320B	$1.311B
YoY Change	4.61%	4.29%	2.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.78M	$20.70M	$19.19M
YoY Change	50.01%	59.95%	13.19%
Accrued Expenses	$143.2M	$124.7M	$144.0M
YoY Change	12.09%	6.38%	8.32%
Deferred Revenue		$7.667M	$0.00
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$860.0K
YoY Change	-100.0%	-100.0%	-82.75%
Total Short-Term Liabilities	$216.9M	$206.4M	$214.5M
YoY Change	9.68%	12.67%	8.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$18.05M	$27.91M	$26.38M
YoY Change	-32.7%	5.29%	32.21%
Total Long-Term Liabilities	$18.05M	$27.91M	$26.38M
YoY Change	-32.7%	5.29%	32.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$216.9M	$206.4M	$214.5M
Total Long-Term Liabilities	$18.05M	$27.91M	$26.38M
Total Liabilities	$391.9M	$393.1M	$400.3M
YoY Change	-0.63%	1.99%	0.6%
SHAREHOLDERS EQUITY
Retained Earnings	$722.2M	$704.7M	$687.6M
YoY Change	8.29%	6.83%	4.71%
Common Stock	$154.0K	$154.0K	$153.0K
YoY Change	0.65%	0.65%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$945.8M	$924.7M	$908.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.340B	$1.320B	$1.311B
YoY Change	4.61%	4.29%	2.77%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$26.84M	$26.21M	$28.41M
YoY Change	64.88%	123.6%	347.13%
Depreciation, Depletion And Amortization	$9.338M	$10.59M	$11.77M
YoY Change	-7.39%	5.35%	12.31%
Cash From Operating Activities	$50.66M	$9.646M	$25.73M
YoY Change	28.84%	-30.39%	115.63%
INVESTING ACTIVITIES
Capital Expenditures	$7.833M	$5.955M	$8.601M
YoY Change	27.39%	-10.32%	52.58%
Acquisitions
YoY Change
Other Investing Activities	$9.258M	$3.540M	-$1.585M
YoY Change	73.73%	-32.09%	-118.72%
Cash From Investing Activities	$1.425M	-$2.415M	-$10.19M
YoY Change	-273.78%	69.24%	-459.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.613M	-$12.07M	-9.834M
YoY Change	-25.89%	-4.37%	-18.73%
NET CHANGE
Cash From Operating Activities	50.66M	$9.646M	25.73M
Cash From Investing Activities	1.425M	-$2.415M	-10.19M
Cash From Financing Activities	-7.613M	-$12.07M	-9.834M
Net Change In Cash	44.47M	-$4.836M	5.713M
YoY Change	57.54%	2458.73%	114.37%
FREE CASH FLOW
Cash From Operating Activities	$50.66M	$9.646M	$25.73M
Capital Expenditures	$7.833M	$5.955M	$8.601M
Free Cash Flow	$42.83M	$3.691M	$17.13M
YoY Change	29.11%	-48.86%	172.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15505096
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	10000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15399724
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15399724
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15350661
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15350661
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.59
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.57
CY2023Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	1606000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	67000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	696386
CY2023Q2	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2023Q2	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-13489
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2057472
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 E. Vine Street
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Murfreesboro
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37130
CY2024Q1	dei	City Area Code CityAreaCode	615
CY2024Q1	dei	Security12b Title Security12bTitle	Common, $0.01 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	NHC
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15399724
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	285823000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	258007000	usd
CY2024Q1	nhc	Other Revenues OtherRevenues	11353000	usd
CY2023Q1	nhc	Other Revenues OtherRevenues	11556000	usd
CY2024Q1	us-gaap	Revenues Revenues	297176000	usd
CY2023Q1	us-gaap	Revenues Revenues	269563000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	183138000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	167824000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	77429000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	71489000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	10348000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	10092000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10586000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10048000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	46000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	98000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	281547000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	259551000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15629000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10012000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5685000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4323000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	14399000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1386000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	35713000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	15721000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9462000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4436000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	26251000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	11285000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	38000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-438000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	26213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	11723000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.71
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.69
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15350240
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15337423
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15356335
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.59
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.57
CY2024Q1	us-gaap	Profit Loss ProfitLoss	26251000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	11285000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-472000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1958000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-45000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	279000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-437000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1679000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	38000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-438000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25776000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13402000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93982000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107076000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	26010000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	17725000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	123040000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	111117000	usd
CY2024Q1	us-gaap	Debt Securities Current DebtSecuritiesCurrent	484000	usd
CY2023Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	5427000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Restricted EquitySecuritiesFvNiRestricted	29616000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Restricted EquitySecuritiesFvNiRestricted	26779000	usd
CY2024Q1	nhc	Restricted Marketable Debt Securities Current RestrictedMarketableDebtSecuritiesCurrent	4790000	usd
CY2023Q4	nhc	Restricted Marketable Debt Securities Current RestrictedMarketableDebtSecuritiesCurrent	12822000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	125664000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	108545000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	6763000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	7386000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6750000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8855000	usd
CY2024Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	487000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	503000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	417586000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	406235000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1065543000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1101681000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	576845000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	608352000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	488698000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	493329000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1140000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1167000	usd
CY2024Q1	nhc	Restricted Marketable Debt Securities Noncurrent RestrictedMarketableDebtSecuritiesNoncurrent	119042000	usd
CY2023Q4	nhc	Restricted Marketable Debt Securities Noncurrent RestrictedMarketableDebtSecuritiesNoncurrent	109478000	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	13738000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14786000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	87356000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94201000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	168295000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	168295000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7038000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7038000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	16747000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	16267000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	413356000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	411232000	usd
CY2024Q1	us-gaap	Assets Assets	1319640000	usd
CY2023Q4	us-gaap	Assets Assets	1310796000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	20697000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	19194000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	860000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29733000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29352000	usd
CY2024Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	64156000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	84110000	usd
CY2024Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	19988000	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	18369000	usd
CY2024Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	30800000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	30549000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	24302000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	22991000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7667000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	9086000	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	9051000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	206429000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	214476000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56004000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	63175000	usd
CY2024Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	77437000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	72710000	usd
CY2024Q1	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	5708000	usd
CY2023Q4	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	6376000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	19639000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	17200000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27909000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26379000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	393126000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	400316000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	154000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	153000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	226909000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	227604000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	704726000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	687599000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7041000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6604000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	924748000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	908752000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	1766000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1728000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	926514000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	910480000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1319640000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1310796000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	26251000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	11285000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10586000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10048000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	67000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1535000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	14399000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1386000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	344000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-492000	usd
CY2024Q1	nhc	Gain Loss On Sale Of Unconsolidated Company GainLossOnSaleOfUnconsolidatedCompany	1024000	usd
CY2023Q1	nhc	Gain Loss On Sale Of Unconsolidated Company GainLossOnSaleOfUnconsolidatedCompany	-0	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2484000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-331000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	793000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	639000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17119000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3148000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-623000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-142000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3153000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1957000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	55000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-316000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1503000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4018000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-19954000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-15800000	usd
CY2024Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	1619000	usd
CY2023Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	48000	usd
CY2024Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4978000	usd
CY2023Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	3157000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	7667000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1311000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	5407000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1530000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	6554000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9646000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13857000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5955000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6640000	usd
CY2024Q1	nhc	Proceeds From Sale Of Unconsolidated Company ProceedsFromSaleOfUnconsolidatedCompany	2100000	usd
CY2023Q1	nhc	Proceeds From Sale Of Unconsolidated Company ProceedsFromSaleOfUnconsolidatedCompany	0	usd
CY2024Q1	nhc	Payments For Proceeds From Unconsolidated Investments PaymentsForProceedsFromUnconsolidatedInvestments	1488000	usd
CY2023Q1	nhc	Payments For Proceeds From Unconsolidated Investments PaymentsForProceedsFromUnconsolidatedInvestments	-0	usd
CY2024Q1	nhc	Payments For Proceeds From Notes Receivable Total PaymentsForProceedsFromNotesReceivableTotal	-16000	usd
CY2023Q1	nhc	Payments For Proceeds From Notes Receivable Total PaymentsForProceedsFromNotesReceivableTotal	-2000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8703000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	10281000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11615000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15492000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2415000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1427000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	860000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1218000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	9051000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	8748000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8412000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9900000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2482000	usd
CY2024Q1	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-668000	usd
CY2023Q1	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-171000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12067000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12619000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4836000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-189000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	125968000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	74865000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	121132000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	74676000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93982000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46144000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	27150000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	28532000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121132000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74676000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	910480000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	26251000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-437000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	793000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8413000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	9900000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	9086000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	926514000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	877514000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	11285000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1679000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	639000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2482000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	8733000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	879902000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	46000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	281547000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2024Q1	nhc	Number Of Skilled Nursing Centers NumberOfSkilledNursingCenters	65	pure
CY2024Q1	nhc	Number Of Beds NumberOfBeds	8421	pure
CY2024Q1	nhc	Number Of Assisted Living Facilities NumberOfAssistedLivingFacilities	24	pure
CY2024Q1	nhc	Number Of Independent Living Facilities NumberOfIndependentLivingFacilities	5	pure
CY2024Q1	nhc	Number Of Behavioral Health Hospitals NumberOfBehavioralHealthHospitals	3	pure
CY2024Q1	nhc	Number Of Homecare Programs NumberOfHomecarePrograms	35	pure
CY2024Q1	nhc	Number Of Hospice Agencies NumberOfHospiceAgencies	30	pure
CY2024Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	8	pure
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Estimates and Assumptions</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</p>
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2471000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1811000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	9174000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8054000	usd
CY2024Q1	nhc	Paymens Received Government Assistance Medicare Accelerated And Advance Payment Program PaymensReceivedGovernmentAssistanceMedicareAcceleratedAndAdvancePaymentProgram	9881000	usd
CY2024Q1	nhc	Government Assistance Medicare Accelerated And Advance Payment Program Payments Recouped GovernmentAssistanceMedicareAcceleratedAndAdvancePaymentProgramPaymentsRecouped	2214000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7667000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15629000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5685000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6164000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5653000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	183138000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	77429000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	10348000	usd
CY2024Q1	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	1606000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10586000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	285823000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	258007000	usd
CY2024Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1	pure
CY2023Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1	pure
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7667000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5959000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	6043000	usd
CY2024Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	4438000	usd
CY2023Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	4097000	usd
CY2024Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	872000	usd
CY2023Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1048000	usd
CY2024Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	84000	usd
CY2023Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	368000	usd
CY2024Q1	nhc	Other Revenues OtherRevenues	11353000	usd
CY2023Q1	nhc	Other Revenues OtherRevenues	11556000	usd
CY2024Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	2056000	usd
CY2023Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1233000	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2538000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1555000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1535000	usd
CY2024Q1	nhc	Gain Loss On Sale Of Unconsolidated Company GainLossOnSaleOfUnconsolidatedCompany	1024000	usd
CY2023Q1	nhc	Gain Loss On Sale Of Unconsolidated Company GainLossOnSaleOfUnconsolidatedCompany	0	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5685000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4323000	usd
CY2024Q1	nhc	Proceeds From Sale Of Unconsolidated Company ProceedsFromSaleOfUnconsolidatedCompany	2100000	usd
CY2024Q1	nhc	Gain Loss On Sale Of Unconsolidated Company GainLossOnSaleOfUnconsolidatedCompany	1024000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	285823000	usd
CY2024Q1	nhc	Other Revenues OtherRevenues	11353000	usd
CY2024Q1	us-gaap	Revenues Revenues	297176000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	14399000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	35713000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	258007000	usd
CY2023Q1	nhc	Other Revenues OtherRevenues	11556000	usd
CY2023Q1	us-gaap	Revenues Revenues	269563000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	167824000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	71489000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	10092000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10048000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	98000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	259551000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10012000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4323000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1386000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	15721000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	34351000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	33590000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24933000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	493000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	207000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	21000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	93595000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7858000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	85737000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	29733000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	56004000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15350240
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15337423
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	26213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	11723000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.71
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15350240
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15337423
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	154856
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18912
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15505096
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15356335
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	26213000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	11723000	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.69
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2024Q1	nhc	Marketable Securities Availableforsale Amortized Cost MarketableSecuritiesAvailableforsaleAmortizedCost	187081000	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	276972000	usd
CY2023Q4	nhc	Marketable Securities Availableforsale Amortized Cost MarketableSecuritiesAvailableforsaleAmortizedCost	189648000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	265623000	usd
CY2024Q1	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	1630642
CY2024Q1	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	24734000	usd
CY2023Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	1630642
CY2023Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	24734000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	21299000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	20785000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	19664000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	19328000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	77738000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	73370000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	81517000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	77118000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	32012000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	28925000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	33515000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	30802000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	1361000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	1236000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	642000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	479000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	132410000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	124316000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	135338000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	127727000	usd
CY2024Q1	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	98459000	usd
CY2023Q4	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	84514000	usd
CY2024Q1	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	474000	usd
CY2023Q4	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	928000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	14399000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1386000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	179000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	326000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	8273000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7937000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11615000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	15492000	usd
CY2024Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	344000	usd
CY2023Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-492000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	398104000	usd
CY2024Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	168295000	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2024Q1	us-gaap	Goodwill Goodwill	168295000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7652000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0433	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0452	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.241	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.293	pure
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0264	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0441	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	445144
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	66.62
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	299278
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	54.44
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	103481
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	64.72
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	52407
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	60.58
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	588534
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.3
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	245726
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	94.07
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	137874
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	60.95
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	696386
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	72.93
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	15025015	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	174105
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	68.48
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4531876	usd
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	72.93
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.265	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.282	pure
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	108237000	usd
CY2023Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	103259000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-24-015736-index-headers.html	Edgar Link	pending
0001437749-24-015736-index.html	Edgar Link	pending
0001437749-24-015736.txt	Edgar Link	pending
0001437749-24-015736-xbrl.zip	Edgar Link	pending
ex_662528.htm	Edgar Link	pending
ex_662529.htm	Edgar Link	pending
ex_662530.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nhc-20240331.xsd	Edgar Link	pending
nhc20240331_10q.htm	Edgar Link	pending
nhc20240331_10qimg001.jpg	Edgar Link	pending
nhc-20240331_cal.xml	Edgar Link	unprocessable
nhc-20240331_def.xml	Edgar Link	unprocessable
nhc-20240331_pre.xml	Edgar Link	unprocessable
nhc-20240331_lab.xml	Edgar Link	unprocessable
nhc20240331_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2024 Q2 Form 10-Q Financial Statement

#000143774924015736 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2024 Q2 Form 10-Q Financial Statement

#000143774924015736 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc